REQUEST A DEMO
Total
USD $0.00
Search more companies

Krka-Rus OOO (Russia)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Krka-Rus OOO Profile Updated: August 17, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Russian Download a sample report

Krka, d. d is a pharmaceutical company. The company operates in more than 70 markets, focusing on general prescription medicines produced under their own brands. They are involved in the development, production, marketing, and sale of products for human use, veterinary products, and pharmaceutical and tourist services. Krka is committed to providing quality, safe, and effective medicines and has introduced electronic planning, production documentation, and related automation. They produce more than 16 billion tablets and capsules annually and are one of the world's leading generic pharmaceutical companies.

Headquarters
Moskovskaya, 50
Istra; Moscow Oblast; Postal Code: 143500

Contact Details: Purchase the Krka-Rus OOO report to view the information.

Website: http://www.krka.si/ru

Basic Information
Outstanding Shares:
Purchase the Krka-Rus OOO report to view the information.
Registered Capital:
Purchase the Krka-Rus OOO report to view the information.
Incorporation Date:
August 26, 2002
Key Executives
Purchase this report to view the information.
General Director
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Krka-Rus OOO report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RUB. Absolute financial data is included in the purchased report.
Net sales revenue
19.02%
Total operating revenue
19.02%
Operating profit (EBIT)
6.74%
Net Profit (Loss) for the Period
31.02%
Total assets
28.07%
Total equity
8.24%
Operating Profit Margin (ROS)
-0.96%
Net Profit Margin
0.62%
Return on Equity (ROE)
1.42%
Quick Ratio
-0.08%
Cash Ratio
-0.22%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?